Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis.
Hemalkumar B MehtaStephan EhrhardtThomas J MooreJodi B SegalG Caleb AlexanderPublished in: BMJ open (2020)
While accelerating morbidity and mortality from the COVID-19 pandemic has been paralleled by early and rapid clinical investigation, many trials lack features to optimise their scientific value. Global coordination and increased funding of high-quality research may help to maximise scientific progress in rapidly discovering safe and effective treatments.